Top 50 Medical VC Funds & Investors in Italy (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
CDP Venture Capital
VC Fund
|
13 | Italy, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $488k–$23M |
|
Italian Angels for Growth
VC Fund
|
8 | Italy, United States, United Kingdom | Seed, Angel, Series A | Software, E-Commerce, Health Care | $219k–$14M |
|
Panakes Partners
VC Fund
|
6 | Italy, Switzerland, United Kingdom | Series B, Series A, Series C | Health Care, Medical, Biotechnology | $4.4M–$110M |
|
Innogest Capital
VC Fund
|
6 | Italy, United States, Spain | Series A, Series B | Health Care, Medical, Medical Device | $1.1M–$29M |
|
LIFTT
VC Fund
|
5 | Italy, United Kingdom, France | Seed, Series A | Software, Biotechnology, Manufacturing | $329k–$21M |
|
Invitalia Ventures
VC Fund
|
4 | Italy, United States, United Kingdom | Series A, Seed | Software, Medical, Internet | $658k–$6.2M |
|
INGENIUM Emilia Romagna
VC Fund
|
3 | Italy | Seed, Angel | Medical, Health Care, Privacy | $2.1M–$2.2M |
|
Scientifica Venture Capital
VC Fund
|
3 | Italy, Sweden, Finland | Seed, Pre-Seed | Biotechnology, Health Care, Manufacturing | $209k–$2.9M |
|
Vertis
VC Fund
|
3 | Italy, United States, United Kingdom | Seed, Series A | Software, Biotechnology, Computer | $823k–$10M |
|
Lazio Innova
VC Fund
|
3 | Italy, United Kingdom | Seed, Pre-Seed, Grant | Health Care, Software, Artificial Intelligence | $22k–$1.3M |
|
Indaco Venture Partners
VC Fund
|
3 | Italy, United Kingdom, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Life Science | $3.3M–$110M |
|
Opes Italia
VC Fund
|
2 | Italy, Spain | Series A, Venture - Series Unknown, Seed | E-Commerce, Leisure, Medical | $440k–$7.5M |
|
Principia SGR
VC Fund
|
2 | Italy, United States, United Kingdom | Series A, Seed | Health Care, Biotechnology, Software | $329k–$7.7M |
|
Equiter
VC Fund
|
2 | Italy | Seed, Series B | Medical, Health Care, Information Technology | $2.2M–$3.8M |
|
Neva SGR
VC Fund
|
2 | Italy, United States, Israel | Series B, Series A, Series C | Software, FinTech, Finance | $5.5M–$141M |
|
Lumen Ventures
VC Fund
|
2 | Italy, United States | Seed, Series A, Pre-Seed | Health Care, Medical, Software | $1.3M–$14M |
|
Sefea Impact
VC Fund
|
2 | Italy | Venture - Series Unknown, Seed, Series A | Medical, Health Care, Information Services | $777k–$5.9M |
|
Fin Posillipo Spa
VC Fund
|
2 | Italy | Seed | Medical, Wellness, Health Care | |
|
The Techshop
VC Fund
|
2 | Italy, United Kingdom | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, FinTech | $322k–$120M |
|
3B Future Health Fund
VC Fund
|
2 | United States, Italy, United Kingdom | Series B, Series A | Biotechnology, Therapeutics, Medical | $2.7M–$75M |
|
ENEA Tech e Biomedical
VC Fund
|
2 | Italy, Finland | Venture - Series Unknown, Series A, Grant | Health Care, Biotechnology, Medical Device | $530k–$21M |
|
P101
VC Fund
|
2 | Italy, Spain, United States | Seed, Series A | Software, E-Commerce, Information Technology | $236k–$15M |
|
Toscana Next Fund
VC Fund
|
1 | Italy | Pre-Seed | Medical, Manufacturing, Medical Device | |
|
Maia Ventures
VC Fund
|
1 | Italy | Series A | Medical, Software, Health Care | |
|
Riello Investimenti Partners
VC Fund
|
1 | Italy | Seed | E-Commerce, Food Delivery, Food and Beverage | |
|
CDP Equity
VC Fund
|
1 | Italy, United Kingdom | Seed, Series A | SaaS, Beauty, Events | $2.7M–$4M |
|
Romed
VC Fund
|
1 | Italy | Medical, Wellness, Health Care | ||
|
Finalca
VC Fund
|
1 | Italy | Seed | Medical, Health Care, Biotechnology | |
|
DSM-Firmenich Venturing
VC Fund
|
1 | United States | Series A | Health Care, Biotechnology, Food and Beverage | |
|
Schia Ventures
VC Fund
|
1 | Italy | Medical, Health Care, Biotechnology | ||
|
a|impact
VC Fund
|
1 | Italy | Seed, Venture - Series Unknown | Health Care, Shoes, Fashion | $380k–$1.3M |
|
CRB Inverbío
VC Fund
|
1 | Spain, Mexico | Series A, Seed | Medical, Health Care, Biotechnology | |
|
RECOMEC
VC Fund
|
1 | Italy | Medical, Health Care, Biotechnology | ||
|
Metaventures
VC Fund
|
1 | Italy, Brazil, United Kingdom | Gaming, Medical, PC Games | ||
|
Spindial Group
VC Fund
|
1 | Italy | Medical, Health Care, Biotechnology | ||
|
Embed Capital
VC Fund
|
1 | Italy, Switzerland, United Kingdom | Seed, Pre-Seed | Information Technology, Mobile, Health Care | $132k–$2.1M |
|
Angelini Ventures
VC Fund
|
1 | United States, Italy, Belgium | Series A, Series B, Series C | Health Care, Therapeutics, Biotechnology | |
|
Fincarl
VC Fund
|
1 | Italy | Seed | Medical, Health Care | |
|
50 Partners Health
VC Fund
|
1 | ||||
|
Alecla7
VC Fund
|
1 | Italy | Seed, Pre-Seed, Series A | Advice, Retail, Grocery | |
|
Fondazione Cottino
VC Fund
|
1 | Italy | Seed | Medical, mHealth, Diabetes | |
|
ArchiMed
VC Fund
|
1 | Italy, France, Japan | Private Equity | Health Care, Biotechnology, Pharmaceutical | |
|
RedSeed Ventures
VC Fund
|
1 | Italy, Israel, United Kingdom | Seed, Series A | Retail, Medical, Privacy | $669k–$16M |
|
Fondazione Golinelli
VC Fund
|
1 | Italy | Seed, Pre-Seed | FinTech, Financial Services, AgTech | $122k–$467k |
|
GCM Group
VC Fund
|
1 | Italy | Seed | Medical, Health Care, Biotechnology | |
|
MPM Capital
VC Fund
|
1 | United States, Canada, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical | $9M–$125M |
|
Launch Tennessee
VC Fund
|
1 | United States, China, Italy | Grant, Seed, Series A | Health Care, Software, Medical | $48k–$4M |
|
Claris Ventures
VC Fund
|
1 | Italy, United Kingdom | Seed, Series A, Series B | Biotechnology, Health Care, Life Science | $2.1M–$25M |
|
Andera Partners
VC Fund
|
1 | France, United States, Germany | Series B, Private Equity | Biotechnology, Health Care, Medical | $14M–$247M |
|
VI Partners
VC Fund
|
1 | Switzerland, Germany, United States | Series A, Series B, Seed | Health Care, Biotechnology, Software | $1.3M–$41M |
| Access all 158 VC funds in Italy Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 276
- Round size: Seed $488k–$8.1M; Series A $3.3M–$23M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $197M in 2021
Portfolio highlights
- Klaaryo —
- Macingo — Trasporto, spedizioni e traslochi a basso costo. Trasporti economici di auto, moto, barche e mobili in Italia ed Europa. Confronta prezzi e risparmia il 70%
- Tretau — E-mobility is powered by its core - the electric motor. We at Tau are at the very core of the core: the copper winding wire, the magnetic core, the electrical steel.We just make it bet.
IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Seed, Angel, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 104
- Round size: Seed $329k–$5.9M; Angel $219k–$1.2M; Series A $2.7M–$14M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Cato AI — Cato AI is a Milan-based B2B SaaS startup that uses AI to automate public tender management.
- AUDIOGEN — Generate your sounds with AI. Create an infinite world of sounds - sound effects, samples, and music, instantly. Get Started Free.
- Alomana —
Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250million under management.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series B, Series A, Series C
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 42
- Round size: Series A $4.4M–$79M; Series B $9.9M–$60M; Series C $18M–$110M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
- DISCO Pharmaceuticals — DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
- Endovascular Engineering — Endovascular Engineering is a preclinical stage company developing novel mechanical thrombectomy solutions to address peripheral indications.
We are investors in companies that make the difference. We partner with hard-working entrepreneurial visionaries
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B
- Geography: Italy, United States, Spain
Investor stats
- Total investments: 68
- Round size: Series A $1.1M–$11M; Series B $2.7M–$29M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $99M in 2015
Portfolio highlights
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- Prestiamoci — Prestiamoci is the first community of loans between individuals born in Italy, allowing you to make profitable investment and to obtain loans with installments transparent.With Prestiamoci the providers invest and get Claimants, returning to its original role of the bank safe. Loans shall be paid by people to trustworthy people who want toachieve their life projects, grow their professional activity, better manage expenses and major purchases
- BetaGlue Technologies — BetaGlue Therapeutics develops innovative targeted cancer therapy solutions using its proprietary YntraDose technology for nuclear medicine.
A not-only-profit operating investment company, eager to create a bridge between innovative ideas, territory and capital.
Show more...Investment focus
- Industry: Software, Biotechnology, Manufacturing
- Stage:Seed, Series A
- Geography: Italy, United Kingdom, France
Investor stats
- Total investments: 73
- Round size: Seed $329k–$7.6M; Series A $2.7M–$21M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- CareGlance — CareGlance is the provider of real-time monitoring systems based on SS-OCT technology. Fast, precise and developed for the industry!
- Rainbow Crops — Rainbow Crops is a next-generation Agtech company developing climate-resilient, high-performing crop varieties.
- Wearable Robotics — Wearable Robotics produces and develops wearable robotic systems and exoskeletons for rehabilitation, assistance and human-power augmentation.
Invitalia Ventures SGR manages the “Italia Venture Fund I”, a 87€/Ml sized co-investment fund that invests in early stage operations in Italy. They co-invest up to a maximum of 70% in round A (€ 0.5ML - € 1.5ML) in high growth sectors. Invitalia Ventures, with its network of co-investors not only provides risk capital, but also know-how and anetwork for business development. Main LPs includes the Ministery of Economic Development, the European Investment Bank, Cisco Group, the Sardinian Banking Foundation and Metec Group.They are looking for visionary entrepreneurs who share their passion for innovation. Growth is their mission!!For more information please contact us at info@invitaliaventures.it or visit our website: www.invitaliaventures.it
Show more...Investment focus
- Industry: Software, Medical, Internet
- Stage:Series A, Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 30
- Round size: Seed $658k–$1.6M; Series A $900k–$6.2M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — raised $89M in 2017
Portfolio highlights
- Ecomate — The ESG Rating platform for every company
- BigProfiles — A deep understanding of customers let a company tailor marketing campaigns and CRM strategies, but companies have only basic data about customers (e.g. gender or age). External data sources like Social Networks, Public Registries and Socio-Demographic data contain rich information about billions of people, like job titles, levels of education,interests and habits.BigProfiles is a Customer Intelligence SAAS that leverages external information about persons to enrich customer profiling: it can profile a company's customers with previously unknown information about them. Thanks to its Identity Resolution algorithm (the result of a PHD), it identifies a person’s information scattered among external sources.Through this technology, BigProfiles provides customer base analytics and behavior predictions: using Artificial Intelligence on enriched profiles allows to predict churn, fraud and willingness to buy.
- Codemotion — Codemotion is the ecosystem devoted to innovation, focused on developers and coding, open to all programming languages and technologies. Pioneering spirits, it scout the future to deliver a first class experience to our people. Codemotion is one of the biggest tech-conferences in Europe, with an international network of 30.000 developers and 350speakers coming from all over the world and from the most important IT realities.Codemotion draw in its main conferences, thousands of attendees eager to discuss about hottest topics: it tailor for them disruptive proposals ranging from mobile to UX, develops, cloud, big data, gamedev, security, methods, languages, web, Internet of things. Codemotion is also a startup, providing a bunch of services and activities, for personal and business customers.
INGENIUM Emilia Romagna was started with EUR 5.30 million by the Emilia Romagna region and EUR 1.7 million from fund managers. Managed by META Investment, the nine-year fund operated through the temporary acquisition of minority stakes in high-opportunity technological companies. It is now fully invested.
Show more...Investment focus
- Industry: Medical, Health Care, Privacy
- Stage:Seed, Angel
- Geography: Italy
Investor stats
- Total investments: 5
- Round size: Seed $2.1M–$2.2M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
- GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
- Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.
Scientifica Venture Capital offers private equity and venture capital investment services for Italy based startups and firms.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Seed, Pre-Seed
- Geography: Italy, Sweden, Finland
Investor stats
- Total investments: 16
- Round size: Seed $209k–$2.9M; Pre-Seed $209k–$541k
- Lead/follow: 75% lead, 25% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Relicta — Relicta solution is a water-soluble bioplastic material obtained from fish processing waste and suitable for packaging solutions.
- OhmSpace — OhmSpace provides the satellite market with reliable resistojets.
- LOTO Biotech — LOTO Biotech is a biotechnology platform focused on supporting the development of treatments for rare diseases, particularly those caused by dominant negative genetic mutations.
Vertis is a dynamic and independent investment management company authorised by Bank of Italy. It manages five closed-end funds for qualified investors by participating in research projects, spin-offs, startups and PMI and deals with the investments of the innovative Made in Italy.
Show more...Investment focus
- Industry: Software, Biotechnology, Computer
- Stage:Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 67
- Round size: Seed $823k–$3.7M; Series A $1.5M–$10M
- Lead/follow: 57% lead, 43% follow
- Last fund: Likely still investing — raised $35M in 2021
Portfolio highlights
- Relicta — Relicta solution is a water-soluble bioplastic material obtained from fish processing waste and suitable for packaging solutions.
- Quido AI — Quido is the co-pilot for investment professionals. Quido allows private capital professionals to streamline data retrieval and data analysis and dramatically increase their efficiency.
- Butterfly Decisions — Traccia, Qualifica e Velocizza Processi e Decisioni nella tua organizzazione attraverso algoritmi ed approccio scientifico
Lazio Innova is a venture capital firm with its headquarters in Rome in Italy. The firm provides services in areas such as credit support and guarantees, interventions in risk capital, internationalization services, promotion of business networks and services for the creation and enterprise development.
Show more...Investment focus
- Industry: Health Care, Software, Artificial Intelligence
- Stage:Seed, Pre-Seed, Grant
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 27
- Round size: Seed $186k–$1.3M; Grant $22k–$409k; Pre-Seed $53k–$549k
- Lead/follow: 44% lead, 56% follow
- Last fund: May invest from a new fund soon — raised $27M in 2018
Portfolio highlights
- HEU — HEU is a legaltech company that automates and manages legal documents and allows users to edit and share them.
- Tech4All — We support the study by using AI.
- GeneSys Bio — Antimicrobial Resistance (AMR) is a global health emergency projected to cause 10 million deaths annually by 2050. The crisis is fueled by slow, conventional diagnostics that take 3-5 days, forcing the empirical use of broad-spectrum antibiotics and accelerating the spread of superbugs.GeneSys Bio is commercialising a breakthrough solution: afully automated, sample-to-result molecular diagnostic platform that identifies infectious pathogens and their critical antibiotic resistance genes in under 30 minutes with >99% sensitivity and specificity. Our portable, laptop-sized device combines proprietary nucleic acid amplification with an AI-driven engine to deliver clear, actionable results directly to clinicians, veterinarians, and public health officials.Our platform is a modular "One Health" solution, adaptable via disease-specific kits for human, veterinary, and environmental applications. We are entering the market with a diagnostic for Urinary Tract Infections (UTIs), a condition affecting over 500 million people annually and a primary driver of antibiotic misuse. By enabling targeted therapy at the first patient encounter, our platform is set to reduce treatment costs by up to 13%, cut follow-up visits, and decrease mortality from complicated infections by 50%.GeneSys Bio is positioned to capture a significant share of this market by bridging the critical gap between speed, laboratory-grade accuracy, and accessibility. We are not just creating a device; we are building the future of decentralized infectious disease diagnostics to safeguard global health for generations to come
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Series B, Series C
- Geography: Italy, United Kingdom, Switzerland
Investor stats
- Total investments: 47
- Round size: Series A $3.3M–$31M; Series B $8.8M–$89M; Series C $16M–$110M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Newcleo — newcleo is the clean and safe nuclear technology company. Privately funded and headquartered in London, UK, newcleo was launched in 2021 to be a disruptor in the field of nuclear energy. Its mission is to generate safe, clean and inexhaustible energy for the world, through a radically innovative combination of existing, accessible technologies.newcleo is building the next generation system with the goals to: (1) eliminate the need for geological repositories by using a fast neutron flux avoiding production of long life radioactive elements; (2) develop an Accelerator Driven System (ADS), based on the intrinsically safe coupling of a particle accelerator and a sub-critical reactor; (3) accelerate the development of new fuel cycles, including thorium, that provide economic, clean, safe and inexhaustible energy from nuclei and the opportunity to burn the long-lived nuclear waste produced by the old generation of nuclear reactors.With visionary co-founders, newcleo brings together a team of engineers with deep knowledge of nuclear energy with younger recruits with a fresh mindset, working to design an innovative micro Lead Fast Reactor with significant commercial applications, for example in shipping. newcleo wants to be the first step toward the evolution of its industry to become fully respectful of people and the environment. To develop a new, sustainable, and completely safe way of generating nuclear energy that will lead humanity to zero emissions, and to the mitigation of global warming.
- Easy Rain — Leading a new automotive era: our modular ecosystem of virtual sensors and active hardware makes cars and autonomous platforms truly safe in every condition.
- Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
Opes Italia Sicaf Euveca is an impact investing Venture Capital fund. Our aim is to invest in companies based in Italy, or with prevalent activity in the country, and that propose solutions that generate a strong social impact and create positive externalities for the community and the territory.
Show more...Investment focus
- Industry: E-Commerce, Leisure, Medical
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: Italy, Spain
Investor stats
- Total investments: 12
- Round size: Seed $440k–$536k; Series A $2.3M–$7.5M; Venture - Series Unknown $2.2M–$4.9M
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- Baluwo — Toda la ayuda para tu familia en una sola App
- Freedome — Freedome is the leading marketplace for outdoor activities in Italy
- GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.
Principia is an Italian Venture Capital firm with over Eur 80M under management. Currently Principia has two funds investing in digital start ups and expansion capital opportunities and in particular cases, we invest also in seed opportunities.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 50
- Round size: Seed $329k–$3.3M; Series A $1.5M–$7.7M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $187M in 2014
Portfolio highlights
- KLISBio — KLISBio is a medtech company currently developing a variety of regenerative medicine implantable products leveraging the power of silk fibroin to promote an endogenous repair of human soft tissues.
- ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
- WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
Equiter seleziona, realizza e gestisce investimenti infrastrutturali in capitale di rischio finalizzati allo sviluppo socio-economico del territorio.
Show more...Investment focus
- Industry: Medical, Health Care, Information Technology
- Stage:Seed, Series B
- Geography: Italy
Investor stats
- Total investments: 8
- Round size: Seed $2.2M–$3.8M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Busforfun — Shared and Green traveling to experience the world of fun#WeTheFun | Busforfun is a young mobility company traveling in a sustainable, safe and low-cost way across Europe. Busforfun vision is a green and shared mobility to experience the world of fun.#WeTheTech | Busforfun is a combination of high tech-startup, e-commerce-platform andtransportation company, Busforfun is going to establish European largest bus network for events in the short time. Thanks to a powerful search engine, business intelligence, an user-friendly booking system and an extensive route network, Busforfun offers travellers the opportunity to experience the world of fun with lower fares.#WeTheGreen | Our low-emission buses comply with the highest safety and environmental standards, so Busforfun offers a sustainable and convenient alternative to cars. With main partner Treedom, Busforfun plants new trees at any travel worldwide.Live Fun Experience in partnership – our concept for successBusforfun provides customers with great offers at lowest budget, through smart network planning, dynamic price management and an adaptive web engine.Busforfun platform is where the innovation and start-up spirit meet the experience and know-how of traditional bus companies and travel agencies.Incredible success can be attributed to the digitalization of old-fashioned bus travel industry: Busforfun has not suppliers or clients: but partners only!
- Easy Rain — Leading a new automotive era: our modular ecosystem of virtual sensors and active hardware makes cars and autonomous platforms truly safe in every condition.
- Faccin Group — Faccin Group leads in manufacturing top tier metal forming & bending machines. Operating as Faccin, Roundo & Boldrini, we offer unparalleled expertise.
Neva SGR, part of the Intesa Sanpaolo Group and wholly owned by the Intesa Sanpaolo Innovation Center, plans and manages investment funds for professional investors interested in seizing diversification and high-yield opportunities offered by Venture Capital investments. Neva SGR can count on Intesa Sanpaolo Innovation Center’s and Intesa SanpaoloGroup’s strength, financial resources, know-how and network of relationships, a unique source of value on the market. Neva SGR is the perfect blend of strength, reputation and stability of the Intesa Sanpaolo Group and the best practices of international venture capital firms. Neva SGR aims to boost the Italian economy through new technologies and to be market maker of the VC asset class of venture capital in Italy.
Show more...Investment focus
- Industry: Software, FinTech, Finance
- Stage:Series B, Series A, Series C
- Geography: Italy, United States, Israel
Investor stats
- Total investments: 48
- Round size: Series A $5.5M–$75M; Series B $17M–$141M; Series C $40M–$110M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- iwoca — Iwoca provides small business credit finance services in the United Kingdom. It offers finance for businesses for various purposes ranging from bridging short-term cashflow gaps to investing in stock opportunities. It serves retailers, restaurants, hotels, service providers, and more.Christoph Rieche and James Dear founded iwoca on October 1,2011. iwoca's headquarters is located in London in the United Kingdom.
- Cyberint — Cyberint is a global threat intelligence provider focusing on helping its clients to proactively protect their businesses against cyber threats. As a partner to direct-to-consumer businesses worldwide, Cyberint provides organizations with a unique combination of a market-proven digital risk protection platform and expert cyber analysts. Thiscombination enables establishing an effective Cyber Threat Intelligence program while reducing organizations’ TCO. We serve more than 100 brands worldwide across industries as diverse as financial services, retail, gaming, entertainment, and media.
- Straiker — Security for agentic AI applications built from the ground up with fine-tuned models to protect and secure every layer of your agentic AI stack.
Lumen Ventures is a venture capital firm that focuses on seed investments, early-stage investments, and private equity.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: Italy, United States
Investor stats
- Total investments: 9
- Round size: Seed $1.3M–$5.3M; Series A $6M–$14M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $29M in 2020
Portfolio highlights
- qomodo — Qomodo: La piattaforma BNPL innovativa. Rate a tasso zero, approvazioni veloci, transazioni sicure. Rivoluzionaria nell'acquisto per aziende e consumatori.
- Serenis Health — Serenis is a mental health platform that provides psychotherapy with a strong focus on science & impact measurement
- AutoConnexa — Connexa InsTech is a digital and telematics insurance company solution offering unprecedented customer-centricity and flexibility. It was founded in 2021 and its headquarters is located in Bari, Apulia, Italy.
Sefea Impact is an asset management company that setting up and managing closed-end alternative investment funds. It aims to generate social impacts through fundamental tools such as tailored finance, technical assistance, and impact measurement.
Show more...Investment focus
- Industry: Medical, Health Care, Information Services
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: Italy
Investor stats
- Total investments: 8
- Round size: Venture - Series Unknown $777k–$5.9M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Evja — Evja supports growers in optimizing the management and monitoring of irrigation, nutrition and protection of their crops through the use of OPI, the most advanced system for precision agriculture .
- BionIT Labs — We apply IT to Bionics in order to Turn disabilities into New Possibilities
- Planeat.eco — Planeat.eco is the site where you can plan your food shopping in a simple and economical way, starting from the recipes and receiving at home all the ingredients ready for preparation , weighed and divided into compostable containers. They offer their products online.
Familiy Office of Petrone Group
Show more...Investment focus
- Industry: Medical, Wellness, Health Care
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- BetaGlue Technologies — BetaGlue Therapeutics develops innovative targeted cancer therapy solutions using its proprietary YntraDose technology for nuclear medicine.
The Techshop is a venture capital and private equity firm that invests in B2B digital startups.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 25
- Round size: Seed $658k–$8.2M; Pre-Seed $322k–$37M; Series A $8.2M–$120M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Qodeup — Qodeup is a provider of digital menu solutions for restaurants. Their QR code payment method reduces waiting times to zero for customers, increases turnover, and is eco-friendly. They allow customers to pay the bill directly from their smartphone through their QR code payment system.
- Octostar — Octostar is the AI-powered investigative intelligence platform for law enforcement, national security, and financial institutions. Connect the dots and discover the facts across petabytes of data.
- Sustainable Brand Platform — Sustainable Brand Platform is the sustainability intelligence solution for fashion brands and manufacturers to accurately measure and manage their sustainability performance.
Helsinn Investment Fund S.A. is a Luxembourg fund focused on early-stage investments in areas of high unmet patient need.
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Medical
- Stage:Series B, Series A
- Geography: United States, Italy, United Kingdom
Investor stats
- Total investments: 36
- Round size: Series A $2.7M–$43M; Series B $7.4M–$75M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
- Epsilogen — IGEM Therapeutics is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.The company's offerings include IgE-based drugs targeting solid tumors, enabling patients to kill parasites which reside in human tissue, also the home of the solid tumor.
- Kainova Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!ENEA Tech e Biomedical is a private foundation. It seeks to encourage the strengthening of research, development, and industrial reconversion of the biomedical sector.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Venture - Series Unknown, Series A, Grant
- Geography: Italy, Finland
Investor stats
- Total investments: 13
- Round size: Series A $3.3M–$7.7M; Venture - Series Unknown $530k–$21M
- Lead/follow: 92% lead, 8% follow
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
- Recornea — Recornea is a developer of a corneal medical device to restore the physiological curvature of the cornea with clear and predictable clinical outcomes.
- Health Triage — Health Triage researches, designs, and develops clinical data, new technologies, and applications for the health sector. Their research activities focus on the development of new screening protocols and innovative diagnosis processes, exploiting deep learning to facilitate the acquisition of new technologies through data learned from algorithms andneural networks.
P101 is an Italian venture capital firm focused on early-stage investments in the digital sector. Agreement to handle personal data I agree I don't agree
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Seed, Series A
- Geography: Italy, Spain, United States
Investor stats
- Total investments: 111
- Round size: Seed $236k–$4.1M; Series A $2.1M–$15M
- Lead/follow: 63% lead, 37% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Cosmico — We are the platform connecting digital talents with the most ambitious companies, using remote work.We have over 8,000 members and our talents have accelerated dozens of projects alongside big names like Accenture Song, Tangity, Frog, Fjord, Sketchin, EY but also aggressive start-ups like Scalapay, Gimme5, Flowe, Unguess.If you are a digitalprofessional: we offer you a community in which to grow your talent through experiences, networks and cosmic projects.If you are a company: we offer you access to a community of designers, developers and marketers from which to select the talents to accelerate your digital transformation projects. Whether you are a manager or a digital professional, Cosmico is here to help you find your space
- A-Cube — A-Cube is a software company that provides digital solutions to exchange documents with government agencies.
- Incapto Coffee — Incapto Coffee offers the sale of the automatic coffee machine and a subscription system for coffee beans.
Toscana Next Fund is a co-investment fund managed by CDP Venture Capital.
Show more...Investment focus
- Industry: Medical, Manufacturing, Medical Device
- Stage:Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Eye2Drive — EYE2DRIVE is a young company designing and building a new imaging sensor for the autonomous cars. We are based in Tuscany, Italy.
- Valuematic — Valuematic realizza soluzioni per il trattamento e gestione dei dati favorendo il miglioramento nei processi organizzativi e informativi di aziende ed enti.
- Next Generation Robotics — Next Generation Robotics is a company that manufactures robotic systems for inspection and monitoring for the railway industry.
Seeding change by investing in category-defining agri & foodtech ventures.
Show more...Investment focus
- Industry: Medical, Software, Health Care
- Stage:Series A
- Geography: Italy
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Biorsaf — Biorsaf is an IT company that develops mobile apps and web control panels to assist companies to bring efficiency to their operations.
- Lembas — Lembas is redefining nutrition for the GLP-1 era. We craft natural, functional foods designed to work with biology - not against it. Our formulations are built for focus, recovery, and longevity, empowering a new generation of eaters to nourish smarter, not more. Explore how Lembas is re-engineering food for a world where better health begins within.
- ExoLab Italia — Cosmetics Utilizing plant-derived exosomes in cosmetic products boosts skin absorption, enhancing bioavailability and stimulating cells to produce lacking compounds. Their ability to penetrate the dermis ensures maximum efficacy and optimal results for skincare products. more informations Supplements Plant-derived exosomes, rich in nutrients, enhance bioavailability by
Riello Investimenti is a private equity investment firm. The firm prefers to invest in Italian small and medium enterprises within the manufacturing, healthcare, energy, media, and logistics sectors. It was founded in 2001 and is based in Milan, Italy.
Show more...Investment focus
- Industry: E-Commerce, Food Delivery, Food and Beverage
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Soplaya — Soplaya is a B2B food company connecting chefs and farmers to build a diverse, sustainable, and efficient food system.By providing data and transparency to an opaque supply chain, we help chefs to simplify purchases, get a wider selection of products and save money and farmers to increase their margins and get easy access to the market.We lovequality food as much as technology and automation. We are rebels: we love transparency and how the internet is capable of bringing the long tail to the market. We're excited about the fact that the restaurant supply chain hasn't basically changed since 40 years, and was technology reluctant for a long time, but restaurants necessities changed dramatically in the last 3 years.We’re becoming the standard layer for restaurant purchasing across Europe, by bringing transparency and simplicity in the procurement phase, increasing order frequency, promoting lean inventory and food waste reduction.
- Bevy — Bevy is a startup that brings water, beverages and bulky products to consumers' homes.
- ExoLab Italia — Cosmetics Utilizing plant-derived exosomes in cosmetic products boosts skin absorption, enhancing bioavailability and stimulating cells to produce lacking compounds. Their ability to penetrate the dermis ensures maximum efficacy and optimal results for skincare products. more informations Supplements Plant-derived exosomes, rich in nutrients, enhance bioavailability by
CDP Equity is a holding company that has been set up to boost the Italian economy by investing venture capital in companies of "significant national interest" (as envisaged by the decrees of the Ministry of Economy and Finance of 3 May 2011 and 2 July 2014) or in companies with "economic, financial and capital balance, with adequateprospects of profitability and development, capable of generating value for investors"
Show more...Investment focus
- Industry: SaaS, Beauty, Events
- Stage:Seed, Series A
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 9
- Round size: Seed $3.3M–$4M; Series A $2.7M–$3.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Soplaya — Soplaya is a B2B food company connecting chefs and farmers to build a diverse, sustainable, and efficient food system.By providing data and transparency to an opaque supply chain, we help chefs to simplify purchases, get a wider selection of products and save money and farmers to increase their margins and get easy access to the market.We lovequality food as much as technology and automation. We are rebels: we love transparency and how the internet is capable of bringing the long tail to the market. We're excited about the fact that the restaurant supply chain hasn't basically changed since 40 years, and was technology reluctant for a long time, but restaurants necessities changed dramatically in the last 3 years.We’re becoming the standard layer for restaurant purchasing across Europe, by bringing transparency and simplicity in the procurement phase, increasing order frequency, promoting lean inventory and food waste reduction.
- Neuranix — Neuranix develops, manufactures, and markets innovative devices for the diagnosis of ear diseases in the medical and veterinary fields. They own several patents in the audiological field. They create products based on the analysis of the acoustic characteristics of the eardrum and middle ear measured over a broad spectrum of frequencies. Theysupport the diagnosis and monitor the therapy of middle ear pathologies.
- Rubber Conversion — Rubber Conversion provides recycling, product sustainability, custom packaging, environmental impact analysis, material tracking, and online document management. Their customers contact them through phone, email, and online applications.
Romed is an investment firm.
Show more...Investment focus
- Industry: Medical, Wellness, Health Care
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- BetaGlue Technologies — BetaGlue Therapeutics is a life sciences company that delivers radiotherapy from within. Introducing Yntradose, our proprietary product.
Finalca is an Investment Company.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.
DSM-Firmenich Venturing provides venture capital finance for startup firms.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Food and Beverage
- Stage:Series A
- Geography: United States
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- one.bio — BCD Bioscience is an emerging biotechnology spinout from UC Davis that creates ingredients for food and biopharmaceutical applications. The company was founded in 2019 and is headquartered in Davis, California, United States.
- ExoLab Italia — Cosmetics Utilizing plant-derived exosomes in cosmetic products boosts skin absorption, enhancing bioavailability and stimulating cells to produce lacking compounds. Their ability to penetrate the dermis ensures maximum efficacy and optimal results for skincare products. more informations Supplements Plant-derived exosomes, rich in nutrients, enhance bioavailability by
- Enhanced Medical Nutrition — Enhanced Medical Nutrition builds clinical nutrition products to help patients prepare better and recover faster from surgery.
Schia Ventures is investment firm.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!a|impact invests in the prevailing form of equity or quasi-equity, focusing our operations mainly on companies.
Show more...Investment focus
- Industry: Health Care, Shoes, Fashion
- Stage:Seed, Venture - Series Unknown
- Geography: Italy
Investor stats
- Total investments: 4
- Round size: Seed $380k–$1.3M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Id.Eight — D.EIGHT is a brand of eco-friendly sneakers produced from food industry waste and recycled material.
- AmaliaCare — AmaliaCare is a socially conscious company that gives a new perspective to the world of aged care. AmaliaCare are the premier digital employment agency, specializing in profiling the ideal domestic workers using cutting-edge technology for families seeking dependable assistance for loved ones who are no longer self-sufficient.
- HARG - Healthy Aging Research Group — HARG researches, develops, and markets dehydrated food preparations with modified textures. The company ensures nutritional principles are the same or even enhanced when compared to those of a typical meal by using only natural ingredients. The R&D activity done in collaboration with the University of Genoa ensures scientific efficacy. HARGseeks to enhance the health and wellbeing of those who struggle with swallowing.
CRB Inverbio is a private venture capital management firm specialized in life sciences investing in innovative early stage start- ups in biotech, med tech, digital health and medical technologies
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Seed
- Geography: Spain, Mexico
Investor stats
- Total investments: 13
- Lead/follow: no public data
Portfolio highlights
- Nuubo — Nuubo is a Spanish medical device company that develops wireless, wearable technologies to monitor physiological parameters. To do so, Nuubo has a platform known as nECG DYNAMIC PLATFORM, which makes it easier to perform and read an electrocardiogram remotely. Specifically, the system patented by Nuubo is made up of three elements: a biomedicalgarment that allows the electrocardiogram signal to be captured without interfering with the patient’s daily activity; a device that continuously records the information captured by the garment and which also allows the data to be sent wirelessly and in real time for processing; and analysis and visualization software that, using artificial intelligence algorithms, can interpret all of the information transmitted by the wireless device.The devices designed by Nuubo allow patients’ hearts to be monitored for longer periods of time and without feeling uncomfortable or intrusive. The company is headquartered in Madrid, Spain.
- Biocross — Biocross offers diagnostic solutions that can be used during the asymptomatic phase of the diseaseand enable early detection of individuals ..
- Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.
RECOMEC operates as a venture capital firm that primarily invests in the healthcare sector.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
We invest in the Metaverse
Show more...Investment focus
- Industry: Gaming, Medical, PC Games
- Geography: Italy, Brazil, United Kingdom
Investor stats
- Total investments: 3
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- 4MDG — 4MDG focuses on providing various data management services such as registration portal, retail technology and customer registration.
- Dubit — Choose your path in the Metaverse.
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
Spindial Group
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.
Embed Capital directly invests in startups, established or in the process of creation.Embed is mainly focused on innovative companies that:- Are active in the so-called “real economy” sectors: industrials, technology, environment, services, retail or social;- Are characterized by simple and intuitive business models and valuepropositions, and operate in markets or market segments featuring high growth potential;- Present a clear competitive advantage and high barriers-to-entry;- Are cash-generative in the medium term.Given that Embed Capital is not a closed-end fund, it doesn’t have specific time-constrains and it can assess on a project-by-project basis to determine the best time to sell a participation, and sign customized agreements with the entrepreneurs.
Show more...Investment focus
- Industry: Information Technology, Mobile, Health Care
- Stage:Seed, Pre-Seed
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 17
- Round size: Seed $132k–$2.1M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Piantando — Piantando sells plants connected to initiatives for the preservation of the planet engaged in the following areas: land, water, climate, biodiversity and local communities. Each plant is equivalent to a transparent and unique contribution, destined to an initiative certified by our Value Chain. Everyone become ambassadors of a new way of livinggreen and understanding their commitment to the planet.
- FrescoFrigo - Healthy food close to you — FrescoFRIGO is a smart fridge with fresh and quality products designed for the needs of worker. Improve everyday lifestyle, through automated proximity selling of good, fresh and healthy product, innovating technology and user experience.
- The Nemesis — The Nemesis is the playground for play-to-earn games and adventures in virtual worlds. Accessible on both mobile and desktop.
Angelini Ventures is an investment firm.
Show more...Investment focus
- Industry: Health Care, Therapeutics, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: United States, Italy, Belgium
Investor stats
- Total investments: 18
- Lead/follow: no public data
Portfolio highlights
- Therini Bio — Therini Bio is developing novel therapeutics based insights into the role of fibrin in driving chronic innate immune activation.
- Avation Medical — 42 million men and women have symptoms of OAB and incontinence. Vivally can help.
- Neumirna Therapeutics — Founded in 2020, NEUmiRNA focuses on achieving transformative disease modification for neurological conditions.
Fincarl is an investment firm.
Show more...Investment focus
- Industry: Medical, Health Care
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Lab Evo — Lab Evo is an Italian Digital Healthcare startup that allows customers to manage their health online with direct access to laboratory tests.
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Medicud — Medicud develops a device for treating wounds with negative pressure dressing.
Private investment firm founded by Angelomario Moratti in 2015, which mainly focuses on early-stage VC opportunities
Show more...Investment focus
- Industry: Advice, Retail, Grocery
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- Glaut — Glaut is the AI-native platform for market research. Use AI-moderated interviews (AIMI) to collect qualitative insights at scale, with multilingual support, fraud prevention, and real-time analysis.
- Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.
- FidoCommercialista — FidoCommercialista is a team of accountants to offer tax support. They use digital technologies to save customers time and money. They provide tax advice for their clients. They respond to customer inquiries by phone, contact form, and email.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Fondazione Cottino is support young people in their educational path and support for scientific research, technology transfer.
Show more...Investment focus
- Industry: Medical, mHealth, Diabetes
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- D-EYE — D-EYE's technology enables healthcare professionals all over the world to quickly screen for problems, photograph them and then distribute them digitally via various secure wireless solutions. They design and manufacture diagnostic instruments.
ArchiMed is an independent group with funds provided by the team as well as European and American investors, both institutional and private (including a number of successful healthcare entrepreneurs).
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Private Equity
- Geography: Italy, France, Japan
Investor stats
- Total investments: 9
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — raised $761M in 2021
Portfolio highlights
- Agatha — Agatha is a provider of strategic software solutions to the health care and life sciences industry. It is dedicated to helping hospitals, biotechnology, pharmaceutical, contract research organizations, and medical device firms optimize the management of their quality and clinical documentation and processes.
- PlasmidFactory — PlasmidFactory is the leading contract manufacturer and service provider for plasmid DNA and minicircle DNA, custom DNA, In-Stock DNA for AAV and clinical application
- Ceva Santé Animale — Ceva Sante Animale S.A. engages in the research, development, production, and marketing of pharmaceutical products and vaccines for companion and farm animals. They work with welfare and social programmes around the world to bring this vision to life – anywhere their products and know-how can make a difference and with all kinds of partners. FromUganda, working with small-scale livestock owners and vets to stop sleeping sickness in its tracks, to the UK and USA, where they supply the biggest animal welfare charities with Adaptil® collars to help re-home shelter dogs.
RedSeed Ventures is a Venture Capital firm investing in Early Stage Companies and Scaleups, in Europe and more particularly in Italy.
Show more...Investment focus
- Industry: Retail, Medical, Privacy
- Stage:Seed, Series A
- Geography: Italy, Israel, United Kingdom
Investor stats
- Total investments: 9
- Round size: Seed $669k–$1.1M; Series A $2.2M–$16M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Leaf Space — Leaf Space offers a global network of ground stations, providing seamless, cost-effective satellite communication with scalable solutions for all mission sizes.
- WIB Machines — Smart vending machines and smart lockers manufacturer pioneering smart, web-based retail automation globally. Patented solutions enabling next-gen retail.
- CyberRidge — CyberRidge is a deep-tech cybersecurity firm that develops photonic encryption to protect data privacy.
Fondazione Golinelli was born in Bologna in 1988 by the will of the entrepreneur and philanthropist Marino Golinelli with the aim to promote education and training, to promote the culture, to foster intellectual growth and ethics of young people, the citizens of tomorrow.
Show more...Investment focus
- Industry: FinTech, Financial Services, AgTech
- Stage:Seed, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 5
- Round size: Seed $122k–$467k
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Biorfarm — Adotta il tuo Albero, crea il tuo Campo Digitale e ricevi a domicilio la tua frutta biologica. Solo con Biorfarm puoi seguire la crescita dei tuoi frutti!
- EvenFi — Criptalia uses blockchain technology to connect businesses that have projects to be funded with people and organizations who are looking for high-yield investments. We offer an online platform where companies publish their innovative ideas and industrial improvement projects. Investors, people, and institutions can fund these projects by lendingmoney in exchange for a higher interest rate.
- Latitudo40 — Empower sustainable growth with AI-driven satellite insights from Latitudo 40. Unlock precise, real-time data for smarter urban planning, climate risk management, and industry innovation. Enhance resilience and lead with confidence.
GCM Group is an investment firm.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.
Powering Breakthroughs in Life Sciences
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B, Series A, Series C
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 225
- Round size: Series A $9M–$84M; Series B $20M–$125M; Series C $12M–$100M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — raised $850M in 2021
Portfolio highlights
- Chiasma — We are a commercial stage pharmaceutical company focused on developing and delivering innovative new treatments that help improve the lives of people with rare diseases.
- Syndax Pharmaceuticals — Syndax Pharmaceuticals is a clinical-stage pharmaceutical company that focuses on an HDAC inhibitor for solid tumors and hematological tumors. It offers therapies to treat solid tumors and lung, breast, and hematological cancer. The company is developing axatilimab, a monoclonal antibody that blocks the colony-stimulating factor 1 (CSF-1) receptor,in development for chronic Graft versus Host Disease, and entinostat, a class I HDAC inhibitor.Syndax Pharmaceuticals pipeline includes and SNDX-5613, a highly selective inhibitor of the Menin–MLL binding interaction, in development for the treatment of patients with MLLr and NPM1 acute leukemias.
- Portola Pharmaceuticals — As Alexion, AstraZeneca Rare Disease, we are delivering life-changing therapies to people living with rare diseases.
Launch Tennessee provides startup resources to entrepreneurs, including capital sources, mentorship, accelerators, entrepreneurship training and more
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Grant, Seed, Series A
- Geography: United States, China, Italy
Investor stats
- Total investments: 117
- Round size: Seed $517k–$3.8M; Grant $48k–$200k; Series A $400k–$4M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — raised $30M in 2011
Portfolio highlights
- Sage Haven — Sage Haven develops an AI-moderated messaging and calling app designed for children in their early years online. The app issues children a dedicated Sage Haven number and routes messaging and voice calls through its platform while allowing contacts to use services like iMessage or Google Messages. Parents create and verify accounts, approve eachcontact, and supervise conversations from their own phones with alerts, recaps, and safety insights. The service uses automated content moderation to block harmful or inappropriate messages, links, images, and videos before they are sent and to guide children toward safer communication practices. It supports Wi-Fi and cellular use on iOS devices, with tools aimed at reducing exposure to online bullying, spam, and addictive usage patterns. Sage Haven operates as a public benefit corporation balancing commercial activity with a mission to improve children’s mental health and well-being.
- Rebel Audio — Rebel Audio is an agentic podcast platform driven by AI that aims to modernize the production, distribution, and monetization of audio. Rebel Audio is a comprehensive system that simplifies production, publication, analytics, and revenue generation for creators, networks, and media organizations.
- Sendit — Sendit is a healthcare marketplace that enables clinicians and health organizations to collaborate to fill staffing needs.
Claris Ventures is a venture capital firm supporting the best scientists in building successful life sciences companies that will impact people's lives
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Seed, Series A, Series B
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 17
- Round size: Seed $2.1M–$11M; Series A $6.1M–$25M; Series B $7.4M–$20M
- Lead/follow: 59% lead, 41% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Lever Bio — Lever Bio's vision is to be at the forefront of unlocking groundbreaking advancements in biotech, particularly in the field of immuno-oncology. By fostering strategic collaborations with leading researchers, prestigious universities, and innovative research centers, Lever Bio aims to accelerate the development of cutting-edge therapies andtechnologies
- Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
- Haptena Therapeutics — Haptena Therapeutics is a biotechnology company developing innovative approaches for genetically defined cancers.
Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Private Equity
- Geography: France, United States, Germany
Investor stats
- Total investments: 180
- Round size: Series B $14M–$85M; Private Equity $110M–$247M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $466M in 2022
Portfolio highlights
- Senstronic — Senstronic designs and manufactures industrial sensing solutions focused on performance, reliability and technical expertise for demanding applications.
- Inventiva Pharma — Inventiva Pharma is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical needs in the areas of fibrosis, lysosomal storage disorders and oncology.They have built a pipeline backed by a discovery engine with an extensive library ofproprietary molecules, a wholly-owned research and development facility and a team with significant expertise and deep experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging these assets and expertise, they are advancing two clinical candidates in three indications, as well as a deep pipeline of earlier stage programs.
- Rivermark Medical — Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function. Developed by urologists to reliably reduce BPH symptoms with minimal side effects.
Vi Partners is a venture capital firm backing exceptional founders in healthcare and technology across Switzerland and Europe for over 25 years.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Seed
- Geography: Switzerland, Germany, United States
Investor stats
- Total investments: 111
- Round size: Seed $1.3M–$6.5M; Series A $3.7M–$24M; Series B $3.3M–$41M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $117M in 2020
Portfolio highlights
- Equippo.com — Used construction equipment marketplace. Easy and safe. Only inspected machines. Worldwide delivery. Money Back Guaranteed. Buy Now, Pay Later!
- Nexthink — Discover what your employees need, see what they experience, know how they feel. Deliver IT that delights.
- Pay by Shopping (deal united) — paybyshopping.com Domain Name is available to Buy. Grab this great Domain from Daaz. Daaz has the lowest transaction fees in the industry. See our list of GTLD's,CCTLD's, New GTLD's,3N's, 6N's, 3L's, 6L's etc.
Medical VC funding in Italy at a glance
Stats across 114 deals from 158 investors.
Access all 158 VC funds in Italy Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical VC Funds in Italy investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 158 VC funds investing in Italy Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!